Leslie Memsic is an Oncology physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 16 publications with 437 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
436 N Bedford Dr
Ste 105
Beverly Hills, CA 902104323
Telephone
310-278-8200Registry record last updated 19 Nov 2016.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- RTI SURGICAL, INCProgram year20251 payment
- Hologic Sales and Service, LLCProgram year20252 payments
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
59.1%Aromatase Inhibitor45.2%Anastrozole100%Part D≥14 patientsEstrogen Agonist/Antagonist14%Tamoxifen Citrate100%Part D<11 patientsRespiratory
28%Opioid Agonist28%Hydrocodone-Acetaminophen100%Part D≥21 patientsNervous system
12.9%Opioid Agonist12.9%Oxycodone-Acetaminophen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1989–1990 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Splenic Infarction Associated with Anti-Car diolipin Antibody: A Report of Two Cases
The American Surgeon
2004 - COMPARISON OF SPECT AND PLANAR TC-99M SESTAMIBI (MIBI) IN THE EVALUATION OF PRIMARY BREAST CARCINOMA
Clinical Nuclear Medicine
1994 - COMPARISON OF TC-99M SESTAMIBI (MIBI) AND MRI IN SUSPECTED BREAST CANCER PATIENT WITH DENSE BREASTS
Clinical Nuclear Medicine
1994
Similar KOLs
Other experts from the same institution or the same specialty.
Beth Karlan, MD
Cedars-Sinai Medical Center
Raj Makkar, MD
Cedars-Sinai Medical Center
Paul Noble, MD
Cedars-Sinai Medical Center
Stephen Freedland, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”